For rib injuries specifically, the stack addresses the full scope of tissue damage
exclusivity extending to approximately 2032 for key formulations, though some international patents expire as early as March 2026 in India, enabling generic launches by companies such as Natco Pharma and Dr
According to a 2025 systematic review, retatrutide showed the highest weight loss among all medications studied
Based on the evidence, riboflavin deficiency is linked to neuroinflammation and related diseases like migraine (27)
Asia-Pacific is expected to be the fastest-growing region at a CAGR of 9.4% from 2026 to 2033, fueled by the rapidly increasing diabetic population, expanding healthcare infrastructure, rising healthcare expenditure, and improving access to advanced biologic therapies across China, India, Japan, and South Korea